Related Experiment Videos

Incidence of intracavitary thrombus in dilated cardiomyopathy

H Kumar1

  • 1Indira Gandhi Institute of Cardiology, Patna.

Insights

In Idiopathic dilated cardiomyopathy (DCM), intracavitary heart thrombus is rare. This study found no thrombus in 90 patients, suggesting lifelong anticoagulation may not be necessary for all DCM cases.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Idiopathic dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • The risk of thromboembolism in DCM patients necessitates understanding thrombus formation.

Purpose of the Study:

  • To determine the incidence of intracavitary thrombus in patients with idiopathic dilated cardiomyopathy.
  • To evaluate the necessity of lifelong anticoagulation in all DCM cases.

Main Methods:

  • Echocardiography was performed on 90 patients (63 males, 27 females) diagnosed with idiopathic dilated cardiomyopathy.
  • Patients' mean age was 49.5 years, with a mean illness duration of 2.82 years.

Main Results:

  • No intracavitary thrombus was detected in any heart chamber among the 90 patients.
  • Only one patient (1.1%) experienced arterial embolization during the study period.

Conclusions:

  • The low incidence of intracavitary thrombus suggests that routine lifelong anticoagulation may not be universally indicated for idiopathic dilated cardiomyopathy.
  • Risk-benefit assessment is crucial when considering anticoagulation therapy in DCM patients due to its inherent hazards.

Related Concept Videos